Benefit risk assessment and update on the use of docetaxel in the management of breast cancer

Scheryll Alken, Catherine M KellyDepartment of Medical Oncology, Mater Misericordiae University Hospital, Dublin, IrelandAbstract: The objective of this paper is to review the data supporting the use of docetaxel in the treatment of breast cancer, focusing on pharmacokinetics, efficacy in adjuvant a...

Full description

Bibliographic Details
Main Authors: Alken S, Kelly CM
Format: Article
Language:English
Published: Dove Medical Press 2013-10-01
Series:Cancer Management and Research
Online Access:http://www.dovepress.com/benefit-risk-assessment-and-update-on-the-use-of-docetaxel-in-the-mana-a14686